Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco d'Amore

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|April 9, 2022
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma RegistryMaja Dam Andersen, Stephen Hamilton-Dutoit, Lena Modvig, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2019
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trialMargrethe Langer Bro, Christoffer Johansen, Peter Vuust, et al.
AIDS (London, England)|May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma developmentMaja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
Leukemia & Lymphoma|August 25, 2009
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomasJudit M Jørgensen, Flemming B Sørensen, Knud Bendix, et al.
American Journal of Epidemiology|September 30, 2005
Medication use and risk of non-Hodgkin's lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Annals of Hematology|July 18, 2019
Pixantrone beyond monotherapy: a reviewCristina Barrenetxea Lekue, Silvina Grasso Cicala, Sirpa Leppä, et al.
Neuro-Oncology Advances|May 20, 2021
Combined <sup>18</sup>F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changesFrancesco D'Amore, Farida Grinberg, Jörg Mauler, et al.
Environmental Science and Pollution Research International|May 11, 2022
First atmospheric mercury measurements at a coastal site in the Apulia region: seasonal variability and source analysisMaria Martino, Antonella Tassone, Lorenzo Angiuli, et al.
Blood|September 10, 2005
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaMartin Hutchings, Annika Loft, Mads Hansen, et al.
Blood Advances|October 7, 2018
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specifiedMaja Ludvigsen, Martin Bjerregård Pedersen, Kristina Lystlund Lauridsen, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|April 9, 2022
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma - A study from the Danish Lymphoma RegistryMaja Dam Andersen, Stephen Hamilton-Dutoit, Lena Modvig, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2019
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trialMargrethe Langer Bro, Christoffer Johansen, Peter Vuust, et al.
AIDS (London, England)|May 14, 2016
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma developmentMaja Ølholm Vase, Maja Ludvigsen, Knud Bendix, et al.
Leukemia & Lymphoma|August 25, 2009
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomasJudit M Jørgensen, Flemming B Sørensen, Knud Bendix, et al.
American Journal of Epidemiology|September 30, 2005
Medication use and risk of non-Hodgkin's lymphomaEllen T Chang, Karin Ekström Smedby, Henrik Hjalgrim, et al.
Annals of Hematology|July 18, 2019
Pixantrone beyond monotherapy: a reviewCristina Barrenetxea Lekue, Silvina Grasso Cicala, Sirpa Leppä, et al.
Neuro-Oncology Advances|May 20, 2021
Combined <sup>18</sup>F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changesFrancesco D'Amore, Farida Grinberg, Jörg Mauler, et al.
Environmental Science and Pollution Research International|May 11, 2022
First atmospheric mercury measurements at a coastal site in the Apulia region: seasonal variability and source analysisMaria Martino, Antonella Tassone, Lorenzo Angiuli, et al.
Blood|September 10, 2005
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphomaMartin Hutchings, Annika Loft, Mads Hansen, et al.
Blood Advances|October 7, 2018
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specifiedMaja Ludvigsen, Martin Bjerregård Pedersen, Kristina Lystlund Lauridsen, et al.
Pageof 12